<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2244">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05131945</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0654</org_study_id>
    <nct_id>NCT05131945</nct_id>
  </id_info>
  <brief_title>GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a rAndomized Controlled Study (GRAWITAS Study)</brief_title>
  <official_title>GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a rAndomized Controlled Study (GRAWITAS Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare gravity-driven versus wall suction-driven&#xD;
      large volume therapeutic thoracentesis on the development of chest discomfort during the&#xD;
      procedure.&#xD;
&#xD;
      This study is a multicenter, single-blinded, randomized controlled trial designed to compare&#xD;
      chest discomfort between gravity-driven and wall suction-driven therapeutic thoracentesis.&#xD;
      Patients will be stratified by study centers, and randomly assigned to intervention and&#xD;
      control arms; and will remain blinding to their group assignment during the procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aims and Objectives:&#xD;
&#xD;
      The primary objective of this study is to compare gravity-driven versus wall suction-driven&#xD;
      large volume therapeutic thoracentesis on the development of chest discomfort during the&#xD;
      procedure.&#xD;
&#xD;
      Expected Outcomes:&#xD;
&#xD;
      We anticipate that gravity driven therapeutic thoracentesis will result in improved clinical&#xD;
      outcomes compared to wall suction driven thoracentesis, defined by less chest discomfort&#xD;
      throughout the procedure as measured at 5 minutes post-procedure (primary endpoint).&#xD;
&#xD;
      Primary endpoint:&#xD;
&#xD;
      The Global Pain Score will be determined at 5 minutes post-procedure using a VAS 0-100 and&#xD;
      represents the pain experienced by the patient during the entire procedure from the beginning&#xD;
      to the 5-minute post-procedure assessment (&quot;On average, how much discomfort have you felt&#xD;
      during the procedure?&quot;). The primary endpoint is defined as the overall procedural chest pain&#xD;
      scored 5 minutes following the procedure.&#xD;
&#xD;
      This study is a randomized controlled trial designed to compare the changes of chest pain&#xD;
      scores between gravity-driven therapeutic thoracentesis and wall suction-driven&#xD;
      thoracentesis. The estimated minimal clinically important difference of the change is 10.&#xD;
&#xD;
      Secondary endpoints:&#xD;
&#xD;
        1. Duration of procedure timed from the beginning of fluid drainage to catheter removal.&#xD;
&#xD;
        2. Differences in narcotics used after the procedure.&#xD;
&#xD;
        3. Incidence of pneumothorax detected on the post procedural CXR&#xD;
&#xD;
        4. Incidence of clinically apparent re-expansion pulmonary edema&#xD;
&#xD;
        5. Incidence of radiographically apparent re-expansion pulmonary edema detected on the post&#xD;
           procedural CXR&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The overall procedural chest pain questionnaire</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The Global Pain Score will be determined at 5 minutes post-procedure using a VAS 0-100 and represents the pain experienced by the patient during the entire procedure from the beginning to the 5-minute post-procedure assessment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Thoracentesis</condition>
  <condition>Pleural Effusions, Chronic</condition>
  <condition>Pulmonary Edema</condition>
  <arm_group>
    <arm_group_label>Group 1: Standard Suction Thoracentesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment techniques suction is a standard of care and used for draining fluid around the lung.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Gravity Thoracentesis.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment techniques (gravity ) is a standard of care and used for draining fluid around the lung.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Suction Thoracentesis</intervention_name>
    <description>a procedure that removes excess fluid from the space in between your lungs and chest wall</description>
    <arm_group_label>Group 1: Standard Suction Thoracentesis</arm_group_label>
    <arm_group_label>Group 2: Gravity Thoracentesis.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gravity Thoracentesis</intervention_name>
    <description>a procedure that removes excess fluid from the space in between your lungs and chest wall</description>
    <arm_group_label>Group 1: Standard Suction Thoracentesis</arm_group_label>
    <arm_group_label>Group 2: Gravity Thoracentesis.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Referral to pulmonary services for large-volume thoracentesis&#xD;
&#xD;
          2. Presence of a symptomatic moderate or large free-flowing (non-septated) pleural&#xD;
             effusion on the basis of:&#xD;
&#xD;
               1. Chest radiograph: effusion filling ≥ 1/3 the hemithorax, OR&#xD;
&#xD;
               2. CT-scan: maximum AP depth of the effusion ≥ 1/3 of the AP dimension on the axial&#xD;
                  image&#xD;
&#xD;
          3. Age &gt;/= 18&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Inability to provide informed consent&#xD;
&#xD;
          2. Study subject has any disease or condition that interferes with safe completion of the&#xD;
             study including:&#xD;
&#xD;
               1. Coagulopathy, with criteria left at the discretion of the operator&#xD;
&#xD;
               2. Hemodynamic instability with systolic blood pressure &lt;90 mmHg or heart rate &gt; 120&#xD;
                  beats/min, unless deemed to be stable with these values by the attending&#xD;
                  physicians&#xD;
&#xD;
          3. Pleural effusion is smaller than expected on bedside pre-procedure ultrasound&#xD;
&#xD;
          4. Referral is for diagnostic thoracentesis only&#xD;
&#xD;
          5. Presence of more than minimal septations and/or loculations( more than 3) on bedside&#xD;
             pre-procedure ultrasound&#xD;
&#xD;
          6. Inability to sit for the procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horianna Grosu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Horianna Grosu, MD</last_name>
    <phone>(713) 745-2261</phone>
    <email>hbgrosu@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77051</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horiana Grosu, MD</last_name>
      <phone>713-745-2261</phone>
      <email>hbgrosu@mdanderson.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center website</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 27, 2021</study_first_submitted>
  <study_first_submitted_qc>November 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2021</study_first_posted>
  <last_update_submitted>November 22, 2021</last_update_submitted>
  <last_update_submitted_qc>November 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

